Aurobindo Pharma Has among the list of broadest API portfolios between Indian pharmaceutical corporations, with more than two hundred APIs. It can be a number one global manufacturer of semi-artificial penicillins and maintains a strong presence in anti-retrovirals and cardiovascular APIs. The organization’s vertically built-in product provides considerable Price rewards. https://www.tjcy.com/industry-information/api-vs-fdf-vs-intermediates-what-s-the-difference.html